Accessibility Menu
Cyanotech logo

Cyanotech(OTC) CYAN

Current Price$0.53
Market Cap$3.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-47%
5 YearN/A
1 Year+36%
1 Month+36%
Cyanotech last closing stock price
MetricPriceDate
Last closeUSD 0.532026-07-21
Cyanotech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.04%USD 0.532026-07-14
1 month+35.82%USD 0.392026-06-16
3 month+36.13%USD 0.392026-04-22
Year to date+17.71%USD 0.452025-12-31
1 year+35.82%USD 0.392025-07-21
Since inception-47.03%USD 1.001990-10-24

Cyanotech Financials at a Glance

Market Cap

$3.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$26.59M

Net Income (TTM)

-$1.28M

EPS (TTM)

-$0.18

P/E Ratio

-2.99

Dividend

$0.00

Beta (Volatility)

0.20 (Low)

Price

$0.53

Volume

60

Open

$0.41

Previous Close

$0.53

Daily Range

$0.39 - $0.53

52-Week Range

$0.21 - $0.57

Estimated Earnings Date

Feb 9, 2026

CYAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cyanotech

Cyanotech Corporation is a leader in the cultivation, processing, and distribution of natural products derived from microalgae. Established in 1983 and based in Kailua-Kona, Hawaii, the company specializes in health-focused products, including dietary supplements that promote overall wellness.

Products and Services
  • BioAstin Hawaiian Astaxanthin, a potent antioxidant for skin and immune health
  • Hawaiian Spirulina Pacifica, a nutrient-rich supplement for energy and cardiovascular support
  • Contract extraction services for various health food and nutraceutical industries
Growth Outlook
  • Recent quarterly revenue increased to $7.91 million, reflecting strong demand
  • Gross profit margin improved to 30.25% in the latest quarter
  • Expansion into new sales channels is expected to drive future growth
Financial Highlights
  • Trailing twelve months revenue of $25.5 million, showing a steady upward trend
  • Net income for the latest quarter was -$128,000, indicating ongoing challenges
  • Current ratio of 1.02 suggests adequate short-term financial health
Cyanotech Corporation continues to focus on its core products, which are well-regarded in the health and wellness market. The company's recent revenue growth and improved gross profit margin indicate a positive trajectory, despite facing challenges reflected in net income figures. The strategic expansion into new sales channels may further enhance growth potential, making it a noteworthy consideration for investors interested in the health supplement sector.
AI Generated • Jul 3, 2026

Industry

Personal Products

Employees

83

CEO

Matthew K. Custer

Headquarters

Kailua-Kona, HI 96740, US

CYAN Financials

Key Financial Metrics (TTM)

Gross Margin

32.63%

Operating Margin

-2.20%

Net Income Margin

-4.83%

Return on Equity

-16.26%

Return on Capital

-2.98%

Return on Assets

-5.80%

Earnings Yield

-33.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.39M

Volume

60

Avg. Volume

1.12K

Financials (TTM)

Gross Profit

$8.67M

Operating Income

-$585.00K

EBITDA

$2.28M

Operating Cash Flow

-$1.21M

Capital Expenditure

-$228.00K

Free Cash Flow

-$1.44M

Cash & ST Invst.

$810.00K

Total Debt

$11.60M

Cyanotech Performance Analysis

Cyanotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 23,178,000-35.6%
20242024-03-31USD 23,071,000-0.5%
20252025-03-31USD 24,215,0005.0%
20262026-03-31USD 26,587,0009.8%
Cyanotech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-7.6%
Q22025-09-3019.9%
Q32025-12-31-15.8%
Q42026-03-3134.6%
Cyanotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.55N/A
20242024-03-31USD -0.8146.4%
20252025-03-31USD -0.45-43.8%
20262026-03-31USD -0.18-61.3%
Cyanotech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-46.6%
Q22025-09-30100.1%
Q32025-12-31-31200.0%
Q42026-03-3143.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$7.91M

+25.6%

Gross Profit

$2.39M

+37.4%

Gross Margin

30.25%

N/A

Market Cap

$3.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$47.18K

N/A

Employees

83

N/A

Net Income

-$128.00K

+79.6%

EBITDA

$1.92M

+4067.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$810.00K

+215.2%

Total Debt

$11.60M

+0.3%

Accounts Receivable

$3.25M

+66.3%

Inventory

$6.34M

-18.6%

Long Term Debt

$3.76M

-13.8%

Short Term Debt

$7.84M

+8.8%

Return on Assets

-5.80%

N/A

Return on Invested Capital

-5.12%

N/A

Free Cash Flow

$44.00K

+111.1%

Operating Cash Flow

$108.00K

+124.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CMGHFChaoda Modern Agriculture (Holdings) Limited
$0.03+0.00%
PLVFFPlant Veda Foods Ltd.
$0.06+0.00%
RSAURooshine, Inc.
$0.23+0.00%
SVINScheid Vineyards Inc.
$0.69-0.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.28+0.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.22-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.95+0.03%
BMNRBitmine Immersion Technologies
$17.65+0.12%

Questions About CYAN

What is the current price of Cyanotech?

Cyanotech is trading at $0.53 per share.

What is the 52-week range for Cyanotech?

Over the past 52 weeks, Cyanotech has traded between $0.21 and $0.57.

How much debt does Cyanotech have?

As of the most recent reporting period, Cyanotech reported total debt of $11.60M.

How much cash does Cyanotech have on hand?

Cyanotech reported $810.00K in cash and cash equivalents in its most recent financial results.

What is Cyanotech’s dividend yield?

Cyanotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.